annual cash & cash equivalents:
$246.38M-$30.03M(-10.86%)Summary
- As of today (September 19, 2025), IART annual cash & cash equivalents is $246.38 million, with the most recent change of -$30.03 million (-10.86%) on December 31, 2024.
- During the last 3 years, IART annual cash & cash equivalents has fallen by -$267.07 million (-52.02%).
- IART annual cash & cash equivalents is now -52.02% below its all-time high of $513.45 million, reached on December 31, 2021.
Performance
IART Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$253.61M-$19.69M(-7.20%)Summary
- As of today (September 19, 2025), IART quarterly cash & cash equivalents is $253.61 million, with the most recent change of -$19.69 million (-7.20%) on June 30, 2025.
- Over the past year, IART quarterly cash & cash equivalents has dropped by -$43.32 million (-14.59%).
- IART quarterly cash & cash equivalents is now -61.75% below its all-time high of $663.10 million, reached on March 31, 2024.
Performance
IART quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IART Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.9% | -14.6% |
| 3 y3 years | -52.0% | -43.3% |
| 5 y5 years | +23.9% | -29.7% |
IART Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.0% | at low | -61.8% | at low |
| 5 y | 5-year | -52.0% | +23.9% | -61.8% | at low |
| alltime | all time | -52.0% | >+9999.0% | -61.8% | >+9999.0% |
IART Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $253.61M(-7.2%) |
| Mar 2025 | - | $273.30M(-0.1%) |
| Dec 2024 | $246.38M(-10.9%) | $273.57M(-1.5%) |
| Sep 2024 | - | $277.60M(-6.5%) |
| Jun 2024 | - | $296.93M(-55.2%) |
| Mar 2024 | - | $663.10M(+114.5%) |
| Dec 2023 | $276.40M(-39.5%) | $309.10M(+12.9%) |
| Sep 2023 | - | $273.73M(-11.5%) |
| Jun 2023 | - | $309.19M(+0.6%) |
| Mar 2023 | - | $307.37M(-32.7%) |
| Dec 2022 | $456.66M(-11.1%) | $456.66M(-10.8%) |
| Sep 2022 | - | $511.94M(+14.5%) |
| Jun 2022 | - | $447.15M(+9.8%) |
| Mar 2022 | - | $407.09M(-20.7%) |
| Dec 2021 | $513.45M(+9.2%) | $513.45M(+9.2%) |
| Sep 2021 | - | $470.23M(+18.3%) |
| Jun 2021 | - | $397.41M(-2.8%) |
| Mar 2021 | - | $408.98M(-13.0%) |
| Dec 2020 | $470.17M(+136.4%) | $470.17M(+18.6%) |
| Sep 2020 | - | $396.28M(+9.8%) |
| Jun 2020 | - | $360.98M(+0.9%) |
| Mar 2020 | - | $357.71M(+79.8%) |
| Dec 2019 | $198.91M(+43.3%) | $198.91M(-4.4%) |
| Sep 2019 | - | $207.98M(+18.1%) |
| Jun 2019 | - | $176.08M(+12.1%) |
| Mar 2019 | - | $157.03M(+13.1%) |
| Dec 2018 | $138.84M(-20.6%) | $138.84M(-32.6%) |
| Sep 2018 | - | $205.99M(+12.1%) |
| Jun 2018 | - | $183.77M(-3.0%) |
| Mar 2018 | - | $189.40M(+8.3%) |
| Dec 2017 | $174.94M(+71.4%) | $174.94M(-63.7%) |
| Sep 2017 | - | $481.94M(+211.7%) |
| Jun 2017 | - | $154.60M(+14.2%) |
| Mar 2017 | - | $135.40M(+32.7%) |
| Dec 2016 | $102.06M(+112.0%) | $102.06M(-5.2%) |
| Sep 2016 | - | $107.60M(+24.0%) |
| Jun 2016 | - | $86.80M(+12.6%) |
| Mar 2016 | - | $77.09M(+47.7%) |
| Dec 2015 | $48.13M(-32.9%) | $52.20M(-34.2%) |
| Sep 2015 | - | $79.31M(-39.6%) |
| Jun 2015 | - | $131.30M(+64.4%) |
| Mar 2015 | - | $79.87M(+10.9%) |
| Dec 2014 | $71.73M(-40.5%) | $71.99M(-48.7%) |
| Sep 2014 | - | $140.23M(+2.2%) |
| Jun 2014 | - | $137.16M(+6.3%) |
| Mar 2014 | - | $129.04M(+7.0%) |
| Dec 2013 | $120.61M(+24.4%) | $120.61M(+1.5%) |
| Sep 2013 | - | $118.87M(+20.5%) |
| Jun 2013 | - | $98.64M(+10.0%) |
| Mar 2013 | - | $89.69M(-7.5%) |
| Dec 2012 | $96.94M(-3.8%) | $96.94M(-22.9%) |
| Sep 2012 | - | $125.72M(+9.5%) |
| Jun 2012 | - | $114.78M(+2.1%) |
| Mar 2012 | - | $112.42M(+11.5%) |
| Dec 2011 | $100.81M(-21.7%) | $100.81M(-9.2%) |
| Sep 2011 | - | $110.99M(-19.1%) |
| Jun 2011 | - | $137.28M(+31.6%) |
| Mar 2011 | - | $104.35M(-19.0%) |
| Dec 2010 | $128.76M | $128.76M(+55.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $82.83M(-11.5%) |
| Jun 2010 | - | $93.62M(+14.6%) |
| Mar 2010 | - | $81.67M(+13.6%) |
| Dec 2009 | $71.89M(-60.8%) | $71.89M(-32.7%) |
| Sep 2009 | - | $106.75M(-23.0%) |
| Jun 2009 | - | $138.72M(-25.3%) |
| Mar 2009 | - | $185.63M(+1.1%) |
| Dec 2008 | $183.55M(+220.1%) | $183.55M(+67.9%) |
| Sep 2008 | - | $109.34M(+41.4%) |
| Jun 2008 | - | $77.34M(-61.1%) |
| Mar 2008 | - | $199.01M(+247.1%) |
| Dec 2007 | $57.34M(+152.6%) | $57.34M(-55.7%) |
| Sep 2007 | - | $129.50M(+7.2%) |
| Jun 2007 | - | $120.84M(+312.0%) |
| Mar 2007 | - | $29.33M(+20.6%) |
| Dec 2006 | $22.70M(-51.6%) | - |
| Sep 2006 | - | $24.32M(-28.4%) |
| Jun 2006 | - | $33.95M(-60.6%) |
| Mar 2006 | - | $86.18M(-32.3%) |
| Dec 2005 | $46.89M(-32.9%) | $127.22M(-6.3%) |
| Sep 2005 | - | $135.78M(+133.9%) |
| Jun 2005 | - | $58.04M(-24.1%) |
| Mar 2005 | - | $76.47M(-24.1%) |
| Dec 2004 | $69.86M(-11.6%) | $100.81M(+37.4%) |
| Sep 2004 | - | $73.39M(+7.3%) |
| Jun 2004 | - | $68.38M(-35.6%) |
| Mar 2004 | - | $106.17M(-2.2%) |
| Dec 2003 | $78.98M(+81.2%) | $108.55M(-6.0%) |
| Sep 2003 | - | $115.47M(-20.7%) |
| Jun 2003 | - | $145.67M(+12.8%) |
| Mar 2003 | - | $129.15M(+30.6%) |
| Dec 2002 | $43.58M(-2.1%) | $98.86M(-5.2%) |
| Sep 2002 | - | $104.31M(+2.6%) |
| Jun 2002 | - | $101.71M(+13.4%) |
| Mar 2002 | - | $89.72M(+34.5%) |
| Dec 2001 | $44.52M(+216.0%) | $66.70M(+5.2%) |
| Sep 2001 | - | $63.41M(+444.0%) |
| Jun 2001 | - | $11.65M(-39.8%) |
| Mar 2001 | - | $19.37M(+28.0%) |
| Dec 2000 | $14.09M(-27.0%) | $15.14M(-11.2%) |
| Sep 2000 | - | $17.05M(+84.3%) |
| Jun 2000 | - | $9.25M(-60.1%) |
| Dec 1999 | $19.30M(+264.2%) | - |
| Jun 1999 | - | $23.20M(+18.1%) |
| Mar 1999 | - | $19.64M(-2.7%) |
| Dec 1998 | $5.30M(+152.4%) | $20.19M(-13.2%) |
| Sep 1998 | - | $23.25M(-4.7%) |
| Jun 1998 | - | $24.40M(+3.6%) |
| Mar 1998 | - | $23.55M(+1021.6%) |
| Dec 1997 | $2.10M(-82.2%) | $2.10M(-74.4%) |
| Sep 1997 | - | $8.20M(+90.7%) |
| Jun 1997 | - | $4.30M(-51.1%) |
| Mar 1997 | - | $8.80M(-25.4%) |
| Dec 1996 | $11.80M(+162.2%) | $11.80M(+47.5%) |
| Sep 1996 | - | $8.00M(-17.5%) |
| Jun 1996 | - | $9.70M(-19.2%) |
| Mar 1996 | - | $12.00M(+166.7%) |
| Dec 1995 | $4.50M | $4.50M(-37.5%) |
| Sep 1995 | - | $7.20M |
FAQ
- What is Integra LifeSciences Holdings Corporation annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Integra LifeSciences Holdings Corporation?
- What is Integra LifeSciences Holdings Corporation annual cash & cash equivalents year-on-year change?
- What is Integra LifeSciences Holdings Corporation quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Integra LifeSciences Holdings Corporation?
- What is Integra LifeSciences Holdings Corporation quarterly cash & cash equivalents year-on-year change?
What is Integra LifeSciences Holdings Corporation annual cash & cash equivalents?
The current annual cash & cash equivalents of IART is $246.38M
What is the all time high annual cash & cash equivalents for Integra LifeSciences Holdings Corporation?
Integra LifeSciences Holdings Corporation all-time high annual cash & cash equivalents is $513.45M
What is Integra LifeSciences Holdings Corporation annual cash & cash equivalents year-on-year change?
Over the past year, IART annual cash & cash equivalents has changed by -$30.03M (-10.86%)
What is Integra LifeSciences Holdings Corporation quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IART is $253.61M
What is the all time high quarterly cash & cash equivalents for Integra LifeSciences Holdings Corporation?
Integra LifeSciences Holdings Corporation all-time high quarterly cash & cash equivalents is $663.10M
What is Integra LifeSciences Holdings Corporation quarterly cash & cash equivalents year-on-year change?
Over the past year, IART quarterly cash & cash equivalents has changed by -$43.32M (-14.59%)